Related Experiment Videos
Squamous cell carcinoma arising in chronic osteomyelitis
1Department of Orthopaedic Surgery and Trauma, Ankara University School of Medicine, Turkey.
International Orthopaedics
|February 1, 2002
Summary
Squamous cell carcinoma (SCC) is a rare complication of chronic osteomyelitis. Amputation remains the primary treatment, with a 15% mortality rate observed in this study.
Area of Science:
- Oncology
- Orthopedic Surgery
- Pathology
Background:
- Squamous cell carcinoma (SCC) is a known, though infrequent, complication of chronic osteomyelitis.
- Chronic osteomyelitis presents a long-term risk for malignant transformation.
Purpose of the Study:
- To report on the incidence, treatment, and outcomes of SCC in patients with chronic osteomyelitis.
- To evaluate the efficacy of amputation as a treatment for this rare complication.
Main Methods:
- Retrospective review of 13 cases of SCC arising in chronic osteomyelitis diagnosed between February 1991 and March 1999.
- Analysis of patient demographics, treatment modalities (amputation vs. limb salvage), follow-up duration, and mortality.
- Assessment of treatment outcomes, with a focus on the role of amputation.
Main Results:
- Thirteen cases of SCC complicating chronic osteomyelitis were identified (12 males, 1 female), with a mean age of 56.5 years.
- Twelve patients underwent amputation, while one had limb salvage surgery.
- The average follow-up was 56 months, and two patients (15.4%) died from the disease.
Conclusions:
- Squamous cell carcinoma is a serious complication of chronic osteomyelitis.
- Amputation is the recommended treatment of choice for SCC arising in chronic osteomyelitis.
- Early diagnosis and aggressive treatment are crucial due to the potential for significant morbidity and mortality.